Male infertility and androgen receptor gene mutations: clinical features and identification of seven novel mutations
Article first published online: 27 JUL 2006
Volume 65, Issue 5, pages 606–610, November 2006
How to Cite
Ferlin, A., Vinanzi, C., Garolla, A., Selice, R., Zuccarello, D., Cazzadore, C. and Foresta, C. (2006), Male infertility and androgen receptor gene mutations: clinical features and identification of seven novel mutations. Clinical Endocrinology, 65: 606–610. doi: 10.1111/j.1365-2265.2006.02635.x
- Issue published online: 4 AUG 2006
- Article first published online: 27 JUL 2006
- (Received 3 February 2006; returned for revision 1 March 2006; finally revised 20 March 2006; accepted 15 May 2006)
Objective Androgens and a functioning androgen receptor (AR) are essential for development and maintenance of the male phenotype and spermatogenesis. Consistent with this, mutations in the AR gene cause a variety of defects related to androgen insensitivity, ranging from complete feminization to phenotypic males with infertility. The aim of his study was to analyse the prevalence of AR gene mutations in male infertility and to clarify the genotype-phenotype relation.
Design Males with infertility were recruited consecutively at the Centre for Male Gamete Cryopreservation at the University of Padova from January 1996 to January 2005.
Patients One thousand five hundred and seventeen men with < 10 million sperm/ml and 310 age-matched normozoospermic controls.
Methods Screening for AR gene mutation was done by DHPLC and sequencing, and reproductive hormone concentrations were measured.
Results We found 20 mutations in 26 of 1517 patients (1·7%) and no mutations in controls. A high number of mutations localized in exon 1 of the AR gene coding for the transactivation domain of the protein. Of 20 mutations, 7 represent novel mutations. With respect to men without AR mutations, subjects with AR mutations have lower ejaculate volume, higher testosterone levels, higher oestradiol levels, and higher androgen sensitivity index. However, the ranges for these variables were highly overlapping between men with and without AR gene mutations. Also clinical manifestations of AR mutations are not unique and 22 men had only spermatogenic impairment.
Conclusions AR gene mutations are quite frequent in unselected infertile men but no specific hormonal or clinical data could be used to preselect patients at risk of mutations.